Gene One Life Science Inc
KRX:011000

Watchlist Manager
Gene One Life Science Inc Logo
Gene One Life Science Inc
KRX:011000
Watchlist
Price: 2 010 KRW -0.99% Market Closed
Market Cap: 171.7B KRW

Net Margin
Gene One Life Science Inc

-145.5%
Current
-132%
Average
-6.4%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-145.5%
=
Net Income
-50.5B
/
Revenue
34.7B

Net Margin Across Competitors

No Stocks Found

Gene One Life Science Inc
Glance View

Market Cap
170.3B KRW
Industry
Biotechnology

GeneOne Life Science, Inc. engages in the research, development, and manufacture of deoxyribonucleic acid (DNA) vaccines for the prevention and treatment of diseases. The company is headquartered in Seoul, Seoul. The firm is a biomedical contract manufacturing organization (CMO). Its textile business engages in the provision of wicks under the brand name of INTERON, which are used in dress shirts, suits and caps. Its biopharmaceutical business engages in the research, development and manufacture of biomedical, plasmid deoxyribonucleic acid (DNA) and DNA vaccines. The company also engaged in the leasing of nonresidential buildings.

Intrinsic Value
2 669.64 KRW
Undervaluation 25%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-145.5%
=
Net Income
-50.5B
/
Revenue
34.7B
What is the Net Margin of Gene One Life Science Inc?

Based on Gene One Life Science Inc's most recent financial statements, the company has Net Margin of -145.5%.

Back to Top